A non-invasive technique that stimulates the auricular branch of the vagus nerve through the ear to activate the parasympathetic nervous system, reduce systemic inflammation, and modulate autonomic function.
The vagus nerve is the longest cranial nerve in the body, serving as the main conduit of the parasympathetic nervous system. It connects the brainstem to the heart, lungs, gut, and immune system. Stimulating the vagus nerve activates the “cholinergic anti-inflammatory pathway,” a neuroimmune circuit that reduces the production of pro-inflammatory cytokines.
Transcutaneous auricular vagus nerve stimulation (taVNS) targets the auricular branch of the vagus nerve, which is accessible at the external ear. This non-invasive approach achieves similar physiological effects to implanted vagus nerve stimulators without surgery.
A small electrode clip is placed on the tragus or cymba conchae of the ear, areas innervated by the auricular branch of the vagus nerve. Low-intensity electrical pulses are delivered to activate vagal afferent fibers, which transmit signals to the nucleus tractus solitarius in the brainstem.
This triggers downstream effects including: reduced TNF-alpha and IL-6 production (anti-inflammatory); increased heart rate variability (improved autonomic balance); enhanced GABA signaling in the brain (anxiolytic and antidepressant effects); and modulation of the gut-brain axis.
taVNS is a gentle, well-tolerated therapy that may complement your treatment program. Our specialists will evaluate whether vagal stimulation is appropriate for your condition.
The patient sits comfortably while a small ear clip electrode is positioned on the outer ear. Stimulation parameters are adjusted to a comfortable level — most patients feel a gentle tingling. Sessions last 20-60 minutes and can be performed daily. The treatment is painless and relaxing; many patients rest or read during sessions. taVNS can also be continued at home with a portable device as part of ongoing care.
taVNS is supported by a growing body of clinical evidence. Studies published in Brain Stimulation, Neurology, and the Journal of Clinical Investigation demonstrate its anti-inflammatory effects and therapeutic benefits in depression, epilepsy, and autonomic dysfunction. The treatment has an excellent safety profile with no serious adverse events reported. It is contraindicated in patients with active ear infections or implanted cardiac devices.
Contact our neuromodulation team to discuss whether taVNS may support your treatment goals.
